Jiang Weiwei,Wang Shuguang,Chen Geng,Zhang Yujun.Simvastatin prevents and treats ischemic-type biliary lesion in rats after liver transplantation[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(12):1325-1328.
Jiang Weiwei,Wang Shuguang,Chen Geng,Zhang Yujun.Simvastatin prevents and treats ischemic-type biliary lesion in rats after liver transplantation[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(12):1325-1328.DOI:
Simvastatin prevents and treats ischemic-type biliary lesion in rats after liver transplantation
Objective To explore the preventive effects of simvastatin on ischemic-type biliary lesion (ITBL) after liver transplantation. Methods Totally 90 female SD rats
6 to 8 weeks old
weighing 200 to 250 g
were randomly divided into 3 groups
sham-operation group (n=10)
control group (n=40
including 20 donors and 20 receipts)
and experimental group (n=40
including 20 donors and 20 receipts). Rat liver transplantation was established by reconstructing hepatic artery. The rats of experimental group were fed with a normal chow containing 0.1% simvastatin for 1 week before operation and for 2 weeks after operation. The donor liver was stored in the University of Wisconsin solution at 4 ℃ for 12 h followed by transplantation. The animals were killed in 2 weeks after operation and the bile
bile duct and liver tissue were taken. High performance liquid chromatography (HPLC) was used to detect the concentrations of bile salts. Biochemistry
histopathology
immunohistochemistry and RT-PCR were employed to measure the level of phospholipids C
observe the pathological changes of liver
detect the protein and mRNA expressions of phospholipid transfer protein (Mdr2 P-glycoprotein). Results The biliary phospholipid composition of rats in the experimental group (3.874 8±1.414 8 mg/dl) was significantly increased
compared with the sham-operation group (1.982 1±0.413 5 mg/dl) and the control group (1.428 5±0.538 7 mg/dl) (P0.05); HE staining showed that the liver bile duct in the control group was severely damaged
while pathological changes in the experimental group were lighter than that of the control group. Bile duct injury severity score ( BDISS) showed the score was (8±1) in the control group and (4±2) in the experimental group
significantly higher than that in the sham-operation group (0
P0.05). The expression of Mdr2 mRNA in experimental group was increased more significantly than that of the control group (P0.05). Conclusion Simvastatin can effectively increase the phospholipid level in bile of rats after transplantation
which attenuates the pathological changes of liver tissue and effectively protects the transplanted bile duct and liver.